Related Experiment Video
Updated: May 25, 2026
Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
Published on: May 13, 2015
Drosophila melanogaster as a model organism for invasive aspergillosis
Michail S Lionakis1, Dimitrios P Kontoyiannis
1Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Abstract:
Mammalian hosts have traditionally been considered the "gold standard" models for studying pathogenesis and antifungal drug activity in invasive aspergillosis (IA). Nevertheless, logistical, economical, and ethical constraints make these host systems difficult to use for high-throughput screening of putative Aspergillus virulence factors and novel antifungal compounds. Here, we present Drosophila melanogaster, a heterologous non-vertebrate host with conserved innate immunity and genetic tractability, as an alternative, easy-to-use, and inexpensive pathosystem for studying Aspergillus pathogenesis and antifungal activity. We describe three different infection protocols (i.e., injection, rolling, ingestion) that introduce Aspergillus conidia at different anatomical sites of Toll-deficient Drosophila flies. These reproducible assays can be used to (1) determine the virulence of various Aspergillus strains and to (2) assess the anti-Aspergillus activity of orally absorbed antifungal agents in vivo. These methods can also be adapted to study pathogenesis and antifungal drug activity against other medically important human fungal pathogens.
Insights
Fruit flies offer a cost-effective model for studying invasive aspergillosis (IA) and antifungal drugs. This research introduces Drosophila melanogaster as a valuable alternative to mammalian hosts for high-throughput screening of virulence factors and drug candidates.
Area of Science:
- Mycology
- Infectious Diseases
- Model Organisms
Background:
- Mammalian models are standard for invasive aspergillosis (IA) research but are costly and difficult for high-throughput screening.
- Limitations of mammalian models hinder the discovery of new antifungal compounds and virulence factors.
Purpose of the Study:
- To establish Drosophila melanogaster as a cost-effective and accessible pathosystem for studying Aspergillus pathogenesis.
- To develop reproducible assays for screening Aspergillus virulence factors and antifungal drug activity.
Main Methods:
- Three infection protocols (injection, rolling, ingestion) were used to introduce Aspergillus conidia into Toll-deficient Drosophila.
- Assays were optimized for different anatomical sites and infection routes.
Main Results:
- Developed reproducible methods to assess Aspergillus virulence and antifungal drug efficacy in Drosophila.
- Demonstrated the utility of Drosophila as a non-vertebrate model for IA research.
Conclusions:
- Drosophila melanogaster provides a valuable, inexpensive, and genetically tractable alternative to mammalian models for studying invasive aspergillosis.
- The developed Drosophila-based assays can accelerate the discovery of novel antifungal therapies and virulence factors for Aspergillus and other fungal pathogens.
